Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Non-cash Items (2024 - 2025)

Bioregenx (BRGX) has 2 years of Non-cash Items data on record, last reported at $41.6 million in Q3 2025.

  • For Q3 2025, Non-cash Items rose 40.85% year-over-year to $41.6 million; the TTM value through Sep 2025 reached $41.6 million, up 40.85%, while the annual FY2024 figure was $1.1 million, N/A changed from the prior year.
  • Non-cash Items reached $41.6 million in Q3 2025 per BRGX's latest filing, up from $35.4 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $41.6 million in Q3 2025 and bottomed at $1.1 million in Q1 2024.